AutoGenomics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:AutoGenomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012919
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AutoGenomics Inc (AutoGenomics) is a provider of automated technologies for test processes inherent in genetic analysis. The company offers infiniti systems and FDA cleared products and RUO products. Its infiniti system is designed for processing AutoGenomics’ unique proprietary BioFilmChip microarrays that can be multiplexed and configured biomarkers to assess disease signatures. The company also offers molecular diagnostic products for the in-vitro diagnostic market. It provides online support services to its customers. The company markets its products in Australia, Ireland, Russia, Spain, Turkey, Colombia, Mexico, the UAE, the US and others. AutoGenomics is headquartered in Carlsbad, California, the US.

AutoGenomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AutoGenomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AutoGenomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AutoGenomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AutoGenomics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
AutoGenomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AutoGenomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
AutoGenomics Raises US$0.2 Million In Venture Financing 10
Partnerships 11
WuXi AppTec Enters into Distribution Agreement with AutoGenomics 11
AutoGenomics Enters into Co-Development Agreement with Genomas for DNA-Guided Diagnostic Systems 12
PGXL Labs Enters Into Collaboration With AutoGenomics 13
Equity Offering 14
AutoGenomics Withdraws IPO for up to USD48.7 Million 14
AutoGenomics Inc – Key Competitors 16
AutoGenomics Inc – Key Employees 17
AutoGenomics Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
Aug 01, 2017: Novel Genetic Test Could Help Combat the Opioid Epidemic by Identifying Patients at Risk of Addiction 19
Other Significant Developments 20
Sep 09, 2016: WuXi AppTec Lab Testing Division and AutoGenomics Form Strategic Partnership to Introduce Advanced Molecular Diagnostic Technology to China 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
AutoGenomics Inc, Medical Equipment, Key Facts 2
AutoGenomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
AutoGenomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
AutoGenomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
AutoGenomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
AutoGenomics Inc, Deals By Market, 2011 to YTD 2017 8
AutoGenomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
AutoGenomics Raises US$0.2 Million In Venture Financing 10
WuXi AppTec Enters into Distribution Agreement with AutoGenomics 11
AutoGenomics Enters into Co-Development Agreement with Genomas for DNA-Guided Diagnostic Systems 12
PGXL Labs Enters Into Collaboration With AutoGenomics 13
AutoGenomics Withdraws IPO for up to USD48.7 Million 14
AutoGenomics Inc, Key Competitors 16
AutoGenomics Inc, Key Employees 17

★海外企業調査レポート[AutoGenomics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anglo Pacific Group plc:企業のM&A・事業提携・投資動向
    Anglo Pacific Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Anglo Pacific Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Twilio Inc (TWLO):企業の財務・戦略的SWOT分析
    Twilio Inc (TWLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Universal Forest Products, Inc.:戦略・SWOT・企業財務分析
    Universal Forest Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Universal Forest Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Optimum General Inc.:企業の戦略・SWOT・財務分析
    Optimum General Inc. - Strategy, SWOT and Corporate Finance Report Summary Optimum General Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • e.l.f. Beauty, Inc. (ELF):企業の財務・戦略的SWOT分析
    e.l.f. Beauty, Inc. (ELF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Iron Mountain Incorporated:企業の戦略・SWOT・財務情報
    Iron Mountain Incorporated - Strategy, SWOT and Corporate Finance Report Summary Iron Mountain Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Oncolys BioPharma Inc (4588)-医療機器分野:企業M&A・提携分析
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OB …
  • ISS AS:企業のM&A・事業提携・投資動向
    ISS AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ISS AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • N V Nederlandse Gasunie:企業の戦略・SWOT・財務分析
    N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report Summary N V Nederlandse Gasunie - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Silver Bull Resources, Inc.:企業の戦略・SWOT・財務情報
    Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Immunicom Inc-医療機器分野:企業M&A・提携分析
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company with focus on the development of a blood filtering device for the treatment of cancer and autoimmune diseases. The company’s lead program, sTNFR Immunopheresis, is a non-drug based cancer therapy that uses a proprietary immunoads …
  • Amorepacific Corp:企業の戦略・SWOT・財務情報
    Amorepacific Corp - Strategy, SWOT and Corporate Finance Report Summary Amorepacific Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Algonquin Power & Utilities Corp (AQN):電力:M&Aディール及び事業提携情報
    Summary Algonquin Power & Utilities Corp. (APUC) generates, transmits and distributes energy. It generates electricity through non-regulated renewable and clean energy and thermal generation facilities across North America. The company distributes electricity in California and New Hampshire; natural …
  • SARIA AS GmbH & Co KG:企業の戦略的SWOT分析
    SARIA AS GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • American States Water Company (AWR):企業の財務・戦略的SWOT分析
    Summary American States Water Company (AWR) is a utility service provider that offers water, wastewater and electric services. The utility provides operation, construction management and maintenance services for water and wastewater systems located on military bases across the US. It offers water se …
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Korea Midland Power Co Ltd:発電所・企業SWOT分析
    Korea Midland Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Soligenix Inc (SNGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures. It develops biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymph …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆